| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.019 | 0.5 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.038 | 0.5 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.02 | 0.5 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |